Rapid Micro Biosystems, Inc. (RPID)
NASDAQ: RPID · Real-Time Price · USD
2.660
-0.020 (-0.75%)
Mar 31, 2025, 2:23 PM EDT - Market open

Company Description

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally.

The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.

Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables.

The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications.

In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software.

Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

Rapid Micro Biosystems, Inc.
Rapid Micro Biosystems logo
Country United States
Founded 2006
IPO Date Jul 15, 2021
Industry Medical Devices
Sector Healthcare
Employees 163
CEO Robert Spignesi

Contact Details

Address:
25 Hartwell Avenue
Lexington, Massachusetts 02421
United States
Phone 978 349 3200
Website rapidmicrobio.com

Stock Details

Ticker Symbol RPID
Exchange NASDAQ
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency USD
IPO Price $20.00
CIK Code 0001380106
CUSIP Number 75340L104
ISIN Number US75340L1044
Employer ID 20-8121647
SIC Code 3826

Key Executives

Name Position
Robert G. Spignesi Jr. Chief Executive Officer, President and Director
Sean M. Wirtjes CPA Chief Financial Officer
John J. Addington Wilson Chief Operating Officer
Michael Beaulieu C.F.A. Vice President of Investor Relations and Corporate Communications
James Xu Vice President of Legal and Secretary
Kristine Williams Senior Vice President of Product

Latest SEC Filings

Date Type Title
Mar 4, 2025 8-K Current Report
Feb 28, 2025 S-8 Securities to be offered to employees in employee benefit plans
Feb 28, 2025 10-K Annual Report
Feb 28, 2025 8-K Current Report
Feb 27, 2025 8-K Current Report
Jan 16, 2025 8-K Current Report
Jan 14, 2025 8-K Current Report
Nov 12, 2024 8-K Current Report
Nov 7, 2024 10-Q Quarterly Report
Nov 1, 2024 8-K Current Report